Clinical Trials Logo

Clinical Trial Summary

While the majority of patients with acute pancreatitis suffer a mild and uncomplicated course of disease, up to 20% develop a more severe course with development of pancreatic and/or peripancreatic necroses. With time, these necroses become encapsulated with a well-defined inflammatory wall, so called walled-off necroses (WON). Up to 30% of WONs become infected, which prolongs the length of hospital stay, increases morbidity and mortality significantly, and generally requires an invasive intervention. During the last decade, minimally invasive therapies consisting of percutaneous and endoscopic, transluminal drainage followed, if necessary, by percutaneous or endoscopic necrosectomy, have replaced open surgery as the standard treatment resulting in better patient outcomes. The investigators have for nearly two decades been practicing an endoscopic step-up approach as standard treatment for infected WON. Recently, lumen apposing metal stents (LAMS) have been introduced for the treatment of pancreatic fluid collections. The stent is fully-covered and shaped with two bilateral anchor flanges with a saddle in between. A dedicated through-the-scope delivery system, where the tip serves as an electro cautery device enables extra-luminal access and deployment of the stent. Initial results from primarily retrospective case series were promising. However, a recent randomized controlled trial failed to demonstrate superiority in terms of number of necrosectomies needed, treatment success, clinical adverse events, readmissions, length of hospital stay (LOS), and overall treatment costs. Furthermore, a number of serious adverse events with development of pseudoaneurisms probably due to collapse of the cavity have led to alterations in treatment with sequential computed tomography (CT) scans and insertion of double pigtail stents within the metal stent. In that trial, the mean diameter of the treated necroses was limited and in addition, the study was launched before the introduction of a novel 20 mm in diameter LAMS. The investigators hypothesize, that use of a 20 mm LAMS in large caliber WON is superior to the standard double pigtail technique. Aim To compare the use of a novel 20 mm lumen apposing metal stent (LAMS) (Hot Axios, Boston Scientific) with a conventional double pigtail technique for endoscopic transluminal drainage of large (> 15 cm) pancreatic and/or peripancreatic walled-of necrosis (WON).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04057846
Study type Interventional
Source Copenhagen University Hospital, Hvidovre
Contact
Status Completed
Phase N/A
Start date August 29, 2019
Completion date May 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04275466 - Perform Necrotic Cavity Lavage or Not After Debridement of Infected Pancreatic Necrosis N/A
Recruiting NCT01992198 - Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis Phase 4
Completed NCT04673552 - Open Surgery for Necrotizing Pancreatitis
Recruiting NCT04033614 - Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study N/A
Active, not recruiting NCT05043415 - Randomized Trial of Immediate Endoscopic Necrosectomy vs. Step-up Endoscopic Interventions in Necrotizing Pancreatitis N/A
Completed NCT04782414 - Hot AXIOS® Prosthesis in Real Life Conditions -